S&P 500   4,282.37
DOW   33,762.76
QQQ   354.65
MarketBeat Week in Review – 5/29 - 6/2
Disturbing Truth About Biden's New Program To Seize Your Cash (Ad)
Biden signs debt ceiling bill that pulls US back from brink of unprecedented default
Russia bans 'unfriendly' countries' journalists from showpiece economic gathering
Disturbing Truth About Biden's New Program To Seize Your Cash (Ad)
Slow start to New York's legal pot market leaves farmers holding the bag
Oil tanker breaks down in Egypt's Suez Canal, disrupting traffic in the global waterway
Save $200 on MarketBeat All Access (Ad)
With oil prices slumping, OPEC+ producers weigh more production cuts
Las Vegas ballpark pitch revives debate over public funding for sports stadiums
S&P 500   4,282.37
DOW   33,762.76
QQQ   354.65
MarketBeat Week in Review – 5/29 - 6/2
Disturbing Truth About Biden's New Program To Seize Your Cash (Ad)
Biden signs debt ceiling bill that pulls US back from brink of unprecedented default
Russia bans 'unfriendly' countries' journalists from showpiece economic gathering
Disturbing Truth About Biden's New Program To Seize Your Cash (Ad)
Slow start to New York's legal pot market leaves farmers holding the bag
Oil tanker breaks down in Egypt's Suez Canal, disrupting traffic in the global waterway
Save $200 on MarketBeat All Access (Ad)
With oil prices slumping, OPEC+ producers weigh more production cuts
Las Vegas ballpark pitch revives debate over public funding for sports stadiums
S&P 500   4,282.37
DOW   33,762.76
QQQ   354.65
MarketBeat Week in Review – 5/29 - 6/2
Disturbing Truth About Biden's New Program To Seize Your Cash (Ad)
Biden signs debt ceiling bill that pulls US back from brink of unprecedented default
Russia bans 'unfriendly' countries' journalists from showpiece economic gathering
Disturbing Truth About Biden's New Program To Seize Your Cash (Ad)
Slow start to New York's legal pot market leaves farmers holding the bag
Oil tanker breaks down in Egypt's Suez Canal, disrupting traffic in the global waterway
Save $200 on MarketBeat All Access (Ad)
With oil prices slumping, OPEC+ producers weigh more production cuts
Las Vegas ballpark pitch revives debate over public funding for sports stadiums
S&P 500   4,282.37
DOW   33,762.76
QQQ   354.65
MarketBeat Week in Review – 5/29 - 6/2
Disturbing Truth About Biden's New Program To Seize Your Cash (Ad)
Biden signs debt ceiling bill that pulls US back from brink of unprecedented default
Russia bans 'unfriendly' countries' journalists from showpiece economic gathering
Disturbing Truth About Biden's New Program To Seize Your Cash (Ad)
Slow start to New York's legal pot market leaves farmers holding the bag
Oil tanker breaks down in Egypt's Suez Canal, disrupting traffic in the global waterway
Save $200 on MarketBeat All Access (Ad)
With oil prices slumping, OPEC+ producers weigh more production cuts
Las Vegas ballpark pitch revives debate over public funding for sports stadiums
NYSE:PRGO

Perrigo (PRGO) Stock Forecast, Price & News

$32.99
+0.93 (+2.90%)
(As of 06/2/2023 ET)
Compare
Today's Range
$32.11
▼
$33.02
50-Day Range
$31.61
▼
$37.62
52-Week Range
$30.78
▼
$43.90
Volume
734,488 shs
Average Volume
1.48 million shs
Market Capitalization
$4.46 billion
P/E Ratio
N/A
Dividend Yield
3.30%
Price Target
$48.00
ProfileAnalyst RatingsChartCompetitorsDividendEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsShort InterestSocial MediaSustainability

Perrigo MarketRank™ Forecast

Analyst Rating
Buy
3.00 Rating Score
Upside/​Downside
45.5% Upside
$48.00 Price Target
Short Interest
Healthy
3.27% of Shares Sold Short
Dividend Strength
Strong
Based on Four Factors
Sustainability
-1.93
Upright™ Environmental Score
News Sentiment
0.32mentions of Perrigo in the last 14 days
Based on 7 Articles This Week
Insider Trading
Selling Shares
$7.69 M Sold Last Quarter
Proj. Earnings Growth
19.77%
From $2.58 to $3.09 Per Share

Overall MarketRank™

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

3.36 out of 5 stars

Medical Sector

2nd out of 983 stocks

Pharmaceutical Preparations Industry

1st out of 486 stocks

See Top Rated MarketRank™ Stocks Here

PRGO stock logo

About Perrigo (NYSE:PRGO) Stock

Perrigo Co. Plc engages in the provision of self-care products and over-the-counter (OTC) health and wellness solutions. It enhances individual well-being by empowering consumers to proactively prevent or treat conditions that can be self-managed. It operates through the following segments: Consumer Self-Care Americas (CSCA) and Consumer Self-Care International (CSCI). The CSCA segment offers OTC solutions, infant formula, oral care, and contract manufacturing in the U.S, Mexico, and Canada. The CSCI segment includes the self-care business branded in Europe, Australia, the United Kingdom, and parts of Europe and Asia. The company was founded by Luther Perrigo in 1887 and is headquartered in Dublin, Ireland.

Receive PRGO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Perrigo and its competitors with MarketBeat's FREE daily newsletter.

PRGO Stock News Headlines

May 16, 2023 | marketbeat.com
Recalled Gerber baby formula was sent to US retailers after recall began, wholesaler says
A Gerber infant formula was recalled earlier this year over potential contamination of Cronobacter sakazakii, a bacteria that could cause life-threatening infections in infants
May 31, 2023 | msn.com
Down -16% in 4 Weeks, Here's Why You Should You Buy the Dip in Perrigo (PRGO)
June 4, 2023 | Behind the Markets (Ad)
"Unknown laser company making HUGE profit from Russia-Ukraine War"
On February 24th, Russia invaded Ukraine. This caused major stock losses and soaring gas prices. But it also created a HUGE opportunity for savvy investors. There's an unknown laser company that's been profiting greatly from this war... ...and from another major conflict happening 3,000 miles away. Learn more here >>>
May 28, 2023 | americanbankingnews.com
Perrigo Company plc (NYSE:PRGO) EVP Buys $96,889.00 in Stock
May 26, 2023 | americanbankingnews.com
Q2 2023 EPS Estimates for Perrigo Company plc Reduced by Analyst (NYSE:PRGO)
May 25, 2023 | finance.yahoo.com
Is Perrigo (PRGO) Stock Undervalued Right Now?
May 24, 2023 | finance.yahoo.com
Perrigo to Host 1x1 Investor Meetings at the 23rd Annual Oppenheimer Consumer Growth & E-Commerce Conference
May 24, 2023 | finance.yahoo.com
FTC investigating baby-formula makers on suspected collusion
June 4, 2023 | Behind the Markets (Ad)
"Unknown laser company making HUGE profit from Russia-Ukraine War"
On February 24th, Russia invaded Ukraine. This caused major stock losses and soaring gas prices. But it also created a HUGE opportunity for savvy investors. There's an unknown laser company that's been profiting greatly from this war... ...and from another major conflict happening 3,000 miles away. Learn more here >>>
May 18, 2023 | seekingalpha.com
Perrigo Company: Still Not Getting There
May 17, 2023 | markets.businessinsider.com
Perrigo: FDA Approves Nicotine Coated Mint Lozenges
May 17, 2023 | americanbankingnews.com
Murray S. Kessler Sells 197,646 Shares of Perrigo Company plc (NYSE:PRGO) Stock
May 16, 2023 | finance.yahoo.com
PERRIGO ANNOUNCES U.S. FDA APPROVAL FOR NICOTINE COATED MINT LOZENGE
May 14, 2023 | finance.yahoo.com
Abortion Bans Can Help Make This Cheap, Accessible Birth Control Pill a Hit
May 12, 2023 | americanbankingnews.com
Perrigo (NYSE:PRGO) Sees Strong Trading Volume After Earnings Beat
May 11, 2023 | markets.businessinsider.com
FDA Panel Votes In Favor Of Perrigo's Birth Control Pill For OTC Use
May 11, 2023 | reuters.com
U.S. FDA advisers back Perrigo birth control pill for over-the-counter use
May 10, 2023 | marketwatch.com
Perrigo Co. PLC stock rises Wednesday, outperforms market
May 10, 2023 | washingtonpost.com
Perrigo: Q1 Earnings Snapshot
May 10, 2023 | msn.com
Perrigo Q1 Earnings Beat Estimates On Strategic Pricing, CEO Plans Retirement
May 10, 2023 | markets.businessinsider.com
Perrigo: Murray Kessler To Retire; Delivers Double-digit Top Line Growth In Q1, Reaffirms Outlook
May 10, 2023 | marketwatch.com
Perrigo Co. PLC stock underperforms Tuesday when compared to competitors
May 10, 2023 | msn.com
Perrigo CEO to retire in July
May 10, 2023 | msn.com
U.S. FDA advisers back OTC use of Perrigo's birth control pill
May 10, 2023 | msn.com
FDA Panel Backs Over-The-Counter Birth Control Pill
May 10, 2023 | finance.yahoo.com
FDA panel backs over-the-counter sales of birth control pill
May 10, 2023 | finance.yahoo.com
FDA Joint Advisory Committee Votes in Favor of Perrigo's Opill® Daily Oral Contraceptive for OTC Use
See More Headlines

PRGO Price History

PRGO Company Calendar

Ex-Dividend for 3/28 Dividend
3/09/2023
Dividend Payable
3/28/2023
Last Earnings
5/09/2023
Ex-Dividend for 6/20 Dividend
6/01/2023
Today
6/04/2023
Dividend Payable
6/20/2023
Next Earnings (Estimated)
8/08/2023
Fiscal Year End
12/31/2023
Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange
NYSE
Industry
Pharmaceutical preparations
Sub-Industry
Pharmaceuticals
Sector
Medical
Current Symbol
NYSE:PRGO
CUSIP
71429010
CIK
1585364
Web
www.perrigo.com
Phone
(531) 709-4000
Fax
269-673-9128
Employees
8,900
Year Founded
1887

Price Target and Rating

Average Stock Price Forecast
$48.00
High Stock Price Forecast
$54.00
Low Stock Price Forecast
$43.00
Forecasted Upside/Downside
+45.5%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
4 Analysts

Profitability

EPS (Most Recent Fiscal Year)
($0.96)
Trailing P/E Ratio
N/A
Forward P/E Ratio
12.79
P/E Growth
N/A
Net Income
$-140,600,000.00
Net Margins
-2.85%
Pretax Margin
-2.67%
Return on Equity
6.21%
Return on Assets
2.73%

Debt

Debt-to-Equity Ratio
0.84
Current Ratio
2.52
Quick Ratio
1.43

Sales & Book Value

Annual Sales
$4.45 billion
Price / Sales
1.00
Cash Flow
$4.73 per share
Price / Cash Flow
6.98
Book Value
$35.72 per share
Price / Book
0.92

Miscellaneous

Outstanding Shares
135,330,000
Free Float
134,379,000
Market Cap
$4.46 billion
Optionable
Optionable
Beta
0.80

Social Links


Key Executives

  • Murray S. Kessler
    President, Chief Executive Officer & Director
  • Ronald C. JanishRonald C. Janish
    Executive VP-Global Operations and Supply Chain
  • Eduardo Guarita Bezerra
    Chief Financial Officer & Executive Vice President
  • Thomas M. FarringtonThomas M. Farrington
    Chief Information Officer & Executive VP
  • Grainne Quinn
    Chief Medical Officer & Executive Vice President

Key Competitors

View All Competitors

Insiders & Institutions

View All Insider Transactions
View All Institutional Transactions













PRGO Stock - Frequently Asked Questions

Should I buy or sell Perrigo stock right now?

4 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Perrigo in the last year. There are currently 4 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" PRGO shares.
View PRGO analyst ratings or view top-rated stocks.

What is Perrigo's stock price forecast for 2023?

4 brokers have issued 12 month price objectives for Perrigo's shares. Their PRGO share price forecasts range from $43.00 to $54.00. On average, they expect the company's share price to reach $48.00 in the next year. This suggests a possible upside of 45.5% from the stock's current price.
View analysts price targets for PRGO or view top-rated stocks among Wall Street analysts.

How have PRGO shares performed in 2023?

Perrigo's stock was trading at $34.09 at the beginning of 2023. Since then, PRGO stock has decreased by 3.2% and is now trading at $32.99.
View the best growth stocks for 2023 here.

When is Perrigo's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Tuesday, August 8th 2023.
View our PRGO earnings forecast.

How were Perrigo's earnings last quarter?

Perrigo Company plc (NYSE:PRGO) issued its quarterly earnings results on Tuesday, May, 9th. The company reported $0.45 earnings per share for the quarter, beating analysts' consensus estimates of $0.42 by $0.03. The business earned $1.18 billion during the quarter, compared to analyst estimates of $1.17 billion. Perrigo had a positive trailing twelve-month return on equity of 6.21% and a negative net margin of 2.85%. The company's quarterly revenue was up 10.0% on a year-over-year basis. During the same quarter last year, the firm earned $0.33 EPS.
Read the conference call transcript.

How often does Perrigo pay dividends? What is the dividend yield for Perrigo?

Perrigo declared a quarterly dividend on Thursday, May 4th. Shareholders of record on Friday, June 2nd will be given a dividend of $0.273 per share on Tuesday, June 20th. This represents a $1.09 dividend on an annualized basis and a yield of 3.31%. The ex-dividend date of this dividend is Thursday, June 1st.
Read our dividend analysis for PRGO.

What ETFs hold Perrigo's stock?

ETFs with the largest weight of Perrigo (NYSE:PRGO) stock in their portfolio include SPDR S&P Pharmaceuticals ETF (XPH), Invesco Dynamic Pharmaceuticals ETF (PJP), AAM Bahl & Gaynor Small/Mid Cap Income Growth ETF (SMIG), Direxion Daily Pharmaceutical & Medical Bull 3X Shares (PILL), ProShares S&P MidCap 400 Dividend Aristocrats ETF (REGL), iShares U.S. Pharmaceuticals ETF (IHE), Alpha Intelligent - Large Cap Value ETF (AILV) and Principal Healthcare Innovators ETF (BTEC).

Is Perrigo a good dividend stock?

Perrigo (NYSE:PRGO) pays an annual dividend of $1.09 per share and currently has a dividend yield of 3.41%.
Read our dividend analysis for PRGO.

What guidance has Perrigo issued on next quarter's earnings?

Perrigo updated its FY 2023 earnings guidance on Tuesday, May, 9th. The company provided earnings per share guidance of $2.50-$2.70 for the period, compared to the consensus EPS estimate of $2.64. The company issued revenue guidance of $4.76 billion-$4.94 billion, compared to the consensus revenue estimate of $4.82 billion.

What is Murray S. Kessler's approval rating as Perrigo's CEO?

38 employees have rated Perrigo Chief Executive Officer Murray S. Kessler on Glassdoor.com. Murray S. Kessler has an approval rating of 83% among the company's employees.

What other stocks do shareholders of Perrigo own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Perrigo investors own include Teva Pharmaceutical Industries (TEVA), Gilead Sciences (GILD), Mylan (MYL), AbbVie (ABBV), Allergan (AGN), Intel (INTC), Johnson & Johnson (JNJ), Netflix (NFLX), QUALCOMM (QCOM) and Amgen (AMGN).

What is Perrigo's stock symbol?

Perrigo trades on the New York Stock Exchange (NYSE) under the ticker symbol "PRGO."

Who are Perrigo's major shareholders?

Perrigo's stock is owned by a variety of institutional and retail investors. Top institutional shareholders include BlackRock Inc. (9.36%), Barrow Hanley Mewhinney & Strauss LLC (6.92%), Dimensional Fund Advisors LP (4.82%), State Street Corp (3.29%), Wolf Hill Capital Management LP (2.93%) and Coho Partners Ltd. (2.73%). Insiders that own company stock include Bradley A Alford, Geoffrey M Parker, Grainne Quinn, James E Dillard III, Murray S Kessler, Raymond Silcock, Richard S Sorota, Rolf A Classon, Ronald Craig Janish, Svend Andersen, Theodore R Samuels II, Thomas Farrington and Todd W Kingma.
View institutional ownership trends.

How do I buy shares of Perrigo?

Shares of PRGO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Perrigo's stock price today?

One share of PRGO stock can currently be purchased for approximately $32.99.

How much money does Perrigo make?

Perrigo (NYSE:PRGO) has a market capitalization of $4.46 billion and generates $4.45 billion in revenue each year. The company earns $-140,600,000.00 in net income (profit) each year or ($0.96) on an earnings per share basis.

How many employees does Perrigo have?

The company employs 8,900 workers across the globe.

Does Perrigo have any subsidiaries?
The following companies are subsidiares of Perrigo: 010414 UK Limited, 251211 UK Limited, Abtei Omega Pharma GmbH, Aco Hud Nordic AB, Adriatic BST Trgovina in Storitve D.o.o., Adriatic Distribution doo Beograd, Agis Industries, Algorithmics Risk Management Limited, Arginet Investments and Property (2003) Ltd., Athena Neurosciences LLC, Aurora Pharmaceuticals Pty Ltd, Biover NV, Blue Wolf Global Limited, Bluewolf International Limited, Brunel Healthcare Manufacturing Limited, CP Kayak Holdings Inc., CanNegev Ltd, Chefaro Ireland Designated Activity Company, Cinetic Laboratories Argentina SA, Cleversafe UK Limited, Cosmediet - Biotechnie SAS, Despharma Kft., Elan Corporation, Elan Europa Finance S.á r.l., Elan International Services Limited, Elan Pharmaceuticals LLC, Fera Pharmaceuticals, Galpharm Healthcare Limited, Galpharm International, Galpharm International Limited, Geiss Destin & Dunn, Gelcaps Exportadora de Mexico S.A. de C.V., Gr8ness LLC, HRA Pharma, Habsont Unlimited Company, Heartbeat Experts Limited, IBM GF international Treasury Company, IBM International Treasury Services Unlimited Company, IBM Netherlands Treasury B.V., Interdelta S.A., International Business Machines Limited, Irish Biosciences Venture Capital Fund, JB Laboratories, JLR Pharma S.A., Jaico R.D.P. NV, Jewel Consumer Care Pvt. Ltd., Kazmira LLC, Kenexa Global Recruitment Services Limited, Kenexa Quorum Holdings Limited, Kenexa Technology LLC, Kiteacre Limited, L. Perrigo Company, Laboratoire de la Mer SAS, Laboratoires Omega Pharma France SAS, Laboratorios DIBA S.A., Laboratorios Diba, Luxembourg Investment Company 289 Sàrl, MH (UK) Limited, Medgenix Benelux NV, Monksland Holdings B.V., Naturwohl Pharma GmbH, ORION Laboratories, Oce Bio BV, Oce-Bio Nederland B.V., Omega Alpharm Cyprus Ltd., Omega Pharma, Omega Pharma AS, Omega Pharma Australia Pty Ltd, Omega Pharma Austria Healthcare GmbH, Omega Pharma Baltics SIA, Omega Pharma Belgium NV, Omega Pharma Capital NV, Omega Pharma Deutschland GmbH, Omega Pharma GmbH, Omega Pharma Hellas SA Health and Beauty Products, Omega Pharma Hungary Kft., Omega Pharma Innovation & Development NV, Omega Pharma International NV, Omega Pharma Limited, Omega Pharma Luxembourg SarL, Omega Pharma Manufacturing GmbH & Co. KG, Omega Pharma Manufacturing Verwaltungs GmbH, Omega Pharma Nederland B.V., Omega Pharma Trading NV, Omega Pharma s.r.o., Omega Teknika Designated Activity Company, OmegaLabs (Pty) Ltd, Oniqua Europe Limited, Optevia Limited, Orion Laboratories (NZ) Ltd., Orion Laboratories PTY Limited, P-Direct NL B.V., P2C Inc., PBM Canada Holdings LLC, PBM China Holdings LLC, PBM Foods LLC, PBM Holdings LLC, PBM International Holdings LLC, PBM Mexico Holdings LLC, PBM Nutritionals LLC, PBM Products, PBM Products LLC, PBM Products Mexico S de R.L. de C.V., PMI Branded Pharmaceuticals Inc., Paddock Laboratories, Paracelsia Pharma GmbH, Perrigo Asia Holding Company Ltd., Perrigo Australian Holding Company II PTY Limited, Perrigo Bulgaria OOD, Perrigo China Business Trust, Perrigo China Business Trustee LLC, Perrigo Company, Perrigo Company Charitable Foundation, Perrigo Company of Tennessee, Perrigo Company plc, Perrigo Corporation Designated Activity Company, Perrigo Danmark A/S, Perrigo Diabetes Care LLC, Perrigo Direct Inc., Perrigo España SA, Perrigo Europe Invest NV, Perrigo Finance (US) LLC, Perrigo Finance Unlimited Company, Perrigo Florida Inc., Perrigo France SAS, Perrigo Global Holdings Inc., Perrigo Holding NV, Perrigo Holdings Unlimited Company, Perrigo International Finance Designated Activity Company, Perrigo International Holdings II Inc., Perrigo International Holdings LLC, Perrigo International Inc., Perrigo International Insurance Limited, Perrigo Ireland 1 Designated Activity Company, Perrigo Ireland 10 Unlimited Company, Perrigo Ireland 11 DAC, Perrigo Ireland 12 Designated Activity Company, Perrigo Ireland 13 Designated Activity Company, Perrigo Ireland 2 Designated Activity Company, Perrigo Ireland 3 Designated Activity Company, Perrigo Ireland 4 Unlimited Company, Perrigo Ireland 5 Unlimited Company, Perrigo Ireland 6 Unlimited Company, Perrigo Ireland 7 Designated Activity Company, Perrigo Ireland 8 Designated Activity Company, Perrigo Ireland 9 Unlimited Company, Perrigo Ireland Holding Company B.V., Perrigo Ireland Management Designated Activity Company, Perrigo Israel Enterprises & Investments Ltd., Perrigo Israel Holdings II B.V., Perrigo Israel Opportunities II Ltd., Perrigo Israel Trading Limited Partnership, Perrigo Italia S.r.l, Perrigo Kişisel Bakım Ürünleri Sanayi ve Ticaret Limited Şirketi, Perrigo LLC, Perrigo Laboratories India Private Limited, Perrigo Management Company, Perrigo Mexico Holding S.A. de C.V., Perrigo Mexico Investment Holdings LLC, Perrigo Netherlands B.V., Perrigo Netherlands Finco 1 Coöperatief U.A., Perrigo Netherlands Finco 2 B.V., Perrigo Netherlands International Partnership C.V., Perrigo New York Inc., Perrigo Norge AS, Perrigo Oral Health Care Holdings Inc., Perrigo Pharma Holding Nederland BV, Perrigo Pharma International Designated Activity Company, Perrigo Pharma Limited, Perrigo Poland Sp.z.o.o, Perrigo Portugal LDA, Perrigo Research & Development Company, Perrigo România S.R.L., Perrigo Sales Corporation, Perrigo Science Eight Unlimited Company, Perrigo Science One Designated Activity Company, Perrigo Suomi Oy, Perrigo Sverige AB, Perrigo Trading (Shanghai) Co. Ltd., Perrigo UK Acquisition Limited, Perrigo UK Finco Limited Partnership, Perrigo Ukraine LLC, Perrigo Ventures Limited Partnership, Perrigo de Mexico S.A. de C.V., Perrigo do Brasil Farmaceutica Ltda., Pharma Clal (1983) Ltd., Promontory Financial Group (UK) Limited, Quimica y Farmacia S.A. de C.V., Ranir, Ranir (Holdings) Limited, Ranir Changshu Oral Care CO. Ltd., Ranir Global Holdings LLC, Ranir LLC, Ranir Limited, Resilient Systems Europe Limited, Richard Bittner AG, Rosemont Pharmaceuticals, Rubicon Healthcare Holdings Pty Ltd, SPSS Limited, Samenwerkende Apothekers Nederland B.V., ScarAway, Silverpop Systems Limited, Simpler Consulting Limited, Solent Dental Company Limited, Solent Oral Care Limited, Sterling Commerce (UK) Limited, The Analytic Sciences Corporation Limited, The Learning Pharmacy Limited, The Weather Channel Global Media Limited, Totalcare International Corp, Transitive Corporation Limited, Transitive Limited, Truven Health Analytics UK Limited, Velcera, Weather Services International Limited, Wrafton Laboratories, Wrafton Laboratories Limited, Zibo Xinhua - Perrigo Pharmaceutical Company Ltd., i2 Holdings Limited, i2 Intermediate Holdings Limited, and i2 Limited.
Read More
How can I contact Perrigo?

Perrigo's mailing address is THE SHARP BUILDING HOGAN PLACE, DUBLIN L2, 49010. The official website for the company is www.perrigo.com. The company can be reached via phone at (531) 709-4000, via email at bradley.joseph@perrigo.com, or via fax at 269-673-9128.

This page (NYSE:PRGO) was last updated on 6/4/2023 by MarketBeat.com Staff

My Account -